DE69833822D1 - Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung - Google Patents

Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung

Info

Publication number
DE69833822D1
DE69833822D1 DE69833822T DE69833822T DE69833822D1 DE 69833822 D1 DE69833822 D1 DE 69833822D1 DE 69833822 T DE69833822 T DE 69833822T DE 69833822 T DE69833822 T DE 69833822T DE 69833822 D1 DE69833822 D1 DE 69833822D1
Authority
DE
Germany
Prior art keywords
tgf
disorders
disorders connected
molecular weight
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833822T
Other languages
English (en)
Inventor
Giovanni Gambaro
Erwin Schleicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69833822D1 publication Critical patent/DE69833822D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
DE69833822T 1998-10-01 1998-10-01 Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung Expired - Lifetime DE69833822D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98118558A EP0998936B1 (de) 1998-10-01 1998-10-01 Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung

Publications (1)

Publication Number Publication Date
DE69833822D1 true DE69833822D1 (de) 2006-05-11

Family

ID=8232731

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833822T Expired - Lifetime DE69833822D1 (de) 1998-10-01 1998-10-01 Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung

Country Status (3)

Country Link
EP (1) EP0998936B1 (de)
AT (1) ATE320261T1 (de)
DE (1) DE69833822D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401253B1 (it) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IL109990A (en) * 1993-06-21 1999-06-20 Lilly Co Eli Materials and methods for screening anti-osteoporosis agents
WO1995019987A1 (en) * 1994-01-25 1995-07-27 The Scripps Research Institute A new sensitive method for quantifying active transforming growth factor-beta and compositions therefor

Also Published As

Publication number Publication date
EP0998936A1 (de) 2000-05-10
ATE320261T1 (de) 2006-04-15
EP0998936B1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
Partlow et al. Dityrosine cross-linking in designing biomaterials
ATE329610T1 (de) Anti-april antikörper und hybridomazellen
Brunger et al. Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage
BRPI0417213A (pt) tratamento de gliomas malìgnos com inibidores de tgf-beta
BR9913532A (pt) Novos inibidores heteroaromáticos de frutose 1,6-bifosfatase
ATE417102T1 (de) Antisense-oligonukleotide (odn) gegen smad7 und ihre verwendung in der medizin
Hong et al. Tyrosinase-mediated construction of a silk fibroin/elastin nanofiber bioscaffold
BRPI0415302A (pt) uso de polimorfismos genéticos que se associam a eficácia de tratamento de doença inflamatória
Butterfield et al. Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial
JP7271180B2 (ja) 神経損傷のための組み合わせ治療
WO2022272248A9 (en) Cbl-b modulators and uses thereof
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
Senturk et al. 3D bioprinting of tyramine modified hydrogels under visible light for osteochondral interface
DE69833822D1 (de) Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung
WO2006067402A3 (en) Agents inibiting the cathelin-like protein cap18/ll-37
Ha et al. Characterization of heparan sulfate from the unossified antler of Cervus elaphus
WO2006136730A3 (fr) Composition cosmetique comprenant un copolymere ampholyte
WO2005094236A9 (en) Activation of hypoxia-inducible gene expression
WO2006119965A3 (en) Growth factor mutants with altered biological attributes
Araujo et al. Glial cells modulate heparan sulfate proteoglycan (HSPG) expression by neuronal precursors during early postnatal cerebellar development
WO2006128885A3 (en) Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
EP3980085A1 (de) Zusammensetzungen und verfahren zu ihrer verwendung für die geweberegeneration
JP7474894B2 (ja) 神経損傷のための組み合わせ治療
CO5280155A1 (es) Metodos para usar 22045, una fosfodiesterasa humana de nucleotidos ciclicos
NO20012849L (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt

Legal Events

Date Code Title Description
8332 No legal effect for de